Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q24009

Entry ID Method Resolution Chain Position Source
AF-Q24009-F1 Predicted AlphaFoldDB

No variants for Q24009

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q24009

No associated diseases with Q24009

9 regional properties for Q24009

Type Name Position InterPro Accession
domain Sterile alpha motif domain 802 - 868 IPR001660
domain K Homology domain 171 - 244 IPR004087-1
domain K Homology domain 323 - 397 IPR004087-2
domain K Homology domain, type 1 176 - 240 IPR004088-1
domain K Homology domain, type 1 327 - 392 IPR004088-2
domain BICC1, SAM domain 805 - 868 IPR037974
domain BICC1, first type I KH domain 85 - 166 IPR047549
domain BICC1, third type I KH domain 325 - 393 IPR047553
domain BICC1, second type I KH 171 - 240 IPR047554

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

1 GO annotations of molecular function

Name Definition
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.

7 GO annotations of biological process

Name Definition
actin cytoskeleton organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
microtubule cytoskeleton organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
mitotic cell cycle Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent.
negative regulation of oskar mRNA translation Any process that stops, prevents or reduces the rate that oskar mRNAs are effectively translated into protein.
oogenesis The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.
ovarian follicle cell migration The directed movement of an ovarian follicle cell that takes place during oogenesis. During egg chamber formation, follicle cells migrate to envelop the germ-line cysts and move in between cysts. At stage 10B, follicle cells migrate centripetally between the nurse cells and the oocyte, enclosing the anterior of the egg. An example of this is found in Drosophila melanogaster.
protein localization Any process in which a protein is transported to, or maintained in, a specific location.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P81021 HDLBP Vigilin Gallus gallus (Chicken) PR
Q00341 HDLBP Vigilin Homo sapiens (Human) PR
Q8VDJ3 Hdlbp Vigilin Mus musculus (Mouse) PR
Q9Z1A6 Hdlbp Vigilin Rattus norvegicus (Rat) PR
P34307 C06G4.1 KH domain-containing protein C06G4.1 Caenorhabditis elegans PR
10 20 30 40 50 60
MLSCASFNKL MYPSAADVAK PPMVGLEVEA GSIGSLSSLH ALPSTTSVGS GAPSETQSEI
70 80 90 100 110 120
SSVDSDWSDI RAIAMKLGVQ NPDDLHTERF KVDRQKLEQL IKAESSIEGM NGAEYFFHDI
130 140 150 160 170 180
MNTTDTYVSW PCRLKIGAKS KKDPHVRIVG KVDQVQRAKE RILSSLDSRG TRVIMKMDVS
190 200 210 220 230 240
YTDHSYIIGR GGNNIKRIMD DTHTHIHFPD SNRSNPTEKS NQVSLCGSLE GVERARALVR
250 260 270 280 290 300
LSTPLLISFE MPVMGPNKPQ PDHETPYIKM IETKFNVQVI FSTRPKLHTS LVLVKGSEKE
310 320 330 340 350 360
SAQVRDATQL LINFACESIA SQILVNVQME ISPQHHEIVK GKNNVNLLSI MERTQTKIIF
370 380 390 400 410 420
PDLSDMNVKP LKKSQVTISG RIDDVYLARQ QLLGNLPVAL IFDFPDNHND ASEIMSLNTK
430 440 450 460 470 480
YGVYITLRQK QRQSTLAIVV KGVEKFIDKI YEARQEILRL ATPFVKPEIP DYYFMPKDKD
490 500 510 520 530 540
LNLAYRTQLT ALLAGYVDSP KTPSLLPPSL AGQLTPYANN NHLLLNANGL ATPTGVCAPT
550 560 570 580 590 600
QKYMQLHNSF QQAQNRSMVA GGQSNNGNYL QVPGAVAPPL KPPTVSPRNS CSQNTSGYQS
610 620 630 640 650 660
FSSSTTSLEQ SYPPYAQLPG TVSSTSSSTA GSQNRAHYSP DSTYGSEGGG VGGGGGGGAR
670 680 690 700 710 720
LGRRLSDGVL LGLSNSNGGG GNSGGAHLLP GSAESYRSLH YDLGGNKHSG HRAFDFDMKR
730 740 750 760 770 780
ALGYKAMERT PVAGELRTPT TAWMGMGLSS TSPAPAPLEN GENGAAGGGA SSGWRLPPGL
790 800 810 820 830 840
GSPYGLSATT GLLDATPVNR RMQLAKHKDI QTLLTSLGLE HYIKIFVLNE IDLEVFTTLT
850 860 870 880 890 900
EENLMELGIA AFGARKKLLT AIHTLLANEA ACSTMPSSSS SQNSSSPRFS GSAAPGAERR
PSNQW